首页> Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research> Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

导出原文传递

翻译打印收藏纠错

作者： Tanaka, Yoshiya ^[1] ; Hirata, Shintaro ^[2] ; Kubo, Satoshi ; Fukuyo, Shunsuke ; Hanami, Kentaro ; Sawamukai, Norifumi ; Nakano, Kazuhisa ; Nakayamada, Shingo ; Yamaoka, Kunihiro ; Sawamura, Fusae ; Saito, Kazuyoshi

作者单位： Univ Occupat & Environm Hlth, Dept Internal Med 1, Sch Med, Kitakyushu, Fukuoka 8078555, Japan ^[1] AbbVie GK, Dept Med, Tokyo, Japan ^[2]

发布时间 2015-03-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of the Rheumatic Diseases

2015年74卷2期

389-395页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Annals of the Rheumatic Diseases

2015年74卷2期

389-395页

检索历史清除

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Annals of the Rheumatic Diseases

相似文献

Annals of the Rheumatic Diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Annals of the Rheumatic Diseases

相似文献

Annals of the Rheumatic Diseases

相关期刊

检索历史清除